FOLD

Amicus' (FOLD) Q1 Loss Wider Than Expected, Sales Up Y/Y

Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q1 2021 Results - Earnings Call Transcript

Recap: Amicus Therapeutics Q1 Earnings

Amicus Therapeutics to Present at Upcoming Investor Conferences in May 2021

Amicus Therapeutics Concludes Pre-BLA Meeting With FDA For AT-GAA In Pompe Disease

Amicus Therapeutics Recognized as a Great Place to Work® in Europe

Amicus Therapeutics to Announce First Quarter 2021 Financial Results on May 10, 2021